Toggle light / dark theme

Companies that are creating rejuvenation biotechnology interventions must develop their products to target individual diseases in order to be approved by the FDA. While that is still the case, this particular FOA is intended to promote broader research that does not necessarily target individual diseases as endpoints.


The National Institutes of Aging in the United States, a component of the National Institutes of Health, is funding clinical trials for interventions that directly affect the root causes of age-related diseases.

Direct funding for trials against aging

Probably the most important and interesting part of this Funding Opportunity Announcement (FOA) is that the NIA specifically mentions “multiple chronic conditions” caused by the processes of aging along with more conventional trials that are targeted directly at specific downstream effects of aging.

When enough anomalies accumulate over time, paradigms change. We may be close to that inflection point right now. At this juncture of technoscientific progress, the boldest of us may admit that we’re overdue for the next post-materialist paradigm: Conventional scientific method is already bankrupt and needs to be supplanted by AI-powered quantum neo-empiricism, computational thinking and the cybernetic approach to reality.

#materialism #physicalism #philosophy #scientificmethod #evolutionarycybernetics


“The only reality is mind and observations but observations are not of things. To see the Universe as it really is, we must abandon our…

Things are getting pretty heated in the South China Sea.


The United States and China are engaged in the first military back-and-forth of the new year, sending many ships and aircraft into the South China Sea over the past few days.

This latest round kicked off with the return of an American carrier battle group to the region, followed by an unprecedented flight of eight Chinese bombers into nearby Taiwan’s air defense identification zone (ADIZ). Both sides piled on more fighters, surveillance aircraft, and bombers, making this dance-off a considerable escalation over previous years.

Dwight E. Bergles, Ph.D., a leading neuroscientist at Johns Hopkins University School of Medicine, is the winner of the prestigious Barancik Prize for Innovation in MS Research. Bergles has pioneered the study of immature cells in the brain that can regenerate myelin-making cells after myelin is destroyed in MS. These cells, oligodendrocyte precursor cells (OPCs), hold the key to finding ways to promote myelin repair and restore function for people living with multiple sclerosis.